A Case of Multiple Myeloma in a 17-Year-Old Girl Treated with Autologous Hematopoietic Stem Cell Transplantation (ASCT)
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment
Huynh Van Man, Phu Chi Dung
Stem Cell Transplantation Department, Blood Transfusion and Hematology Hospital, Ho Chi Minh City, Vietnam
Am J Case Rep 2019; 20:1623-1629
DOI: 10.12659/AJCR.917670
Available online:
Published: 2019-11-05
BACKGROUND:
Multiple myeloma is mainly a disease of the elderly. The diagnosis of multiple myeloma in patients under 30 years of age is rare. A rare case is presented of a 17-year-old girl diagnosed with multiple myeloma who was successfully treated with autologous hematopoietic stem cell transplantation (ASCT).
CASE REPORT:
A 17-year-old Vietnamese girl presented with pain in the left hip and difficulty walking. She was diagnosed with stage IIIA IgG lambda (l) multiple myeloma and was treated with a bortezomib-based chemotherapy regimen followed by ASCT. The patient showed a good response to treatment. At 14-month follow-up, her bone pain had resolved, and her ability to walk was improved.
CONCLUSIONS:
A rare case of multiple myeloma is presented in a 17-year-old girl who responded well to ASCT.
Keywords: Multiple Myeloma, Plasmacytoma, Antineoplastic Agents
